Daewoong Pharmaceutical Co., Ltd. 35-14, Jeyakgongdan 4-Gil, Hyangnam-Eup

FDA inspection history in Hwaseong-Si, South Korea, 2017

1
Form 483

Every document, by year

  • Form 483

2017: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2017One Form 483, at Hwaseong-Si, South Korea.

Cited most

Across all Daewoong Pharmaceutical Co., Ltd. 35-14, Jeyakgongdan 4-Gil, Hyangnam-Eup observations on file

The complete Daewoong Pharmaceutical Co., Ltd. 35-14, Jeyakgongdan 4-Gil, Hyangnam-Eup file.

All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.

$99

The documents one by one, while the file is prepared

See the documents

Sites

Documents

1 on file, newest first
DateDocumentPrice
2017-11-17483 Form 483$99

FEI number 3012333115 · most recent document Nov 17, 2017

About Daewoong Pharmaceutical Co., Ltd. 35-14, Jeyakgongdan 4-Gil, Hyangnam-Eup

How many FDA Form 483s has Daewoong Pharmaceutical Co., Ltd. 35-14, Jeyakgongdan 4-Gil, Hyangnam-Eup received?

FDA Intel has 1 Form 483 on file for Daewoong Pharmaceutical Co., Ltd. 35-14, Jeyakgongdan 4-Gil, Hyangnam-Eup; the most recent is dated Nov 17, 2017.

When was Daewoong Pharmaceutical Co., Ltd. 35-14, Jeyakgongdan 4-Gil, Hyangnam-Eup last inspected by FDA?

The most recent FDA inspection document on file for Daewoong Pharmaceutical Co., Ltd. 35-14, Jeyakgongdan 4-Gil, Hyangnam-Eup is a Form 483 dated Nov 17, 2017, for the site in Hwaseong-Si, South Korea.

What did FDA cite at Daewoong Pharmaceutical Co., Ltd. 35-14, Jeyakgongdan 4-Gil, Hyangnam-Eup?

The regulations cited most in the observations on file for Daewoong Pharmaceutical Co., Ltd. 35-14, Jeyakgongdan 4-Gil, Hyangnam-Eup are 21 CFR 211.192 (Production record review), 1 time.